Epizyme Buy Hold or Sell Recommendation
| EPZMDelisted Stock | USD 1.47 0.00 0.00% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Epizyme is 'Not Rated'. Macroaxis provides Epizyme buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding Epizyme positions. The advice algorithm takes into account all of Epizyme's available fundamental, technical, and predictive indicators you will find on this site. Key drivers impacting Epizyme's buy or sell advice are summarized below:
Real Value 1.04 | Hype Value 1.47 | Market Value 1.47 | Naive Value 1.62 |
A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Epizyme given historical horizon and risk tolerance towards Epizyme. When Macroaxis issues a 'buy' or 'sell' recommendation for Epizyme, the advice is generated through an automated system that utilizes algorithms and statistical models.
Epizyme |
Execute Epizyme Buy or Sell Advice
The Epizyme recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Epizyme. Macroaxis does not own or have any residual interests in Epizyme or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Epizyme's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Not Rated
Epizyme Trading Alerts and Improvement Suggestions
| Epizyme is not yet fully synchronised with the market data | |
| Epizyme may become a speculative penny stock | |
| Epizyme has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 38.49 M. Net Loss for the year was (236.35 M) with profit before overhead, payroll, taxes, and interest of 18.57 M. | |
| Epizyme currently holds about 199.73 M in cash with (210.47 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.21. | |
| Over 90.0% of the company shares are held by institutions such as insurance companies |
Epizyme current analysts advice
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Epizyme analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Epizyme analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
| Target Mean Price | 2.98 | |
| Target Median Price | 1.50 | |
| Target High Price | 6.00 | |
| Recommendation Mean | 2.70 | |
| Number Of Analyst Opinions | 3 | |
| Target Low Price | 1.45 |
The consensus estimates and target price estimation comprises individual analyst assessments, and may or may not mutch the Macroaxis buy or sell advice. It is determined by taking an average of all analyst recommendations and classifying them as Strong Buy, Buy, Hold, or Sell.
Epizyme Returns Distribution Density
The distribution of Epizyme's historical returns is an attempt to chart the uncertainty of Epizyme's future price movements. The chart of the probability distribution of Epizyme daily returns describes the distribution of returns around its average expected value. We use Epizyme price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Epizyme returns is essential to provide solid investment advice for Epizyme.
| Mean Return | 1.74 | Value At Risk | -6.67 | Potential Upside | 14.52 | Standard Deviation | 9.14 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Epizyme historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Epizyme Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Epizyme . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Epizyme Buy or Sell Advice
When is the right time to buy or sell Epizyme? Buying financial instruments such as Epizyme Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Epizyme in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Obamacare Thematic Idea Now
Obamacare
Health care services and providers including hospitals, clinics and nursing homes that hope to benefit from Obamacare program. The Obamacare theme has 37 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Obamacare Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation. Note that the Epizyme information on this page should be used as a complementary analysis to other Epizyme's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.
Other Consideration for investing in Epizyme Stock
If you are still planning to invest in Epizyme check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Epizyme's history and understand the potential risks before investing.
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |